Skip to content

Effects of Dexmedetomidine-Assisted Total Intravenous Anesthesia on Intraoperative Hemodynamic Fluctuations During the Maintenance Phase and Postoperative Recovery Quality in Patients Undergoing Laparoscopic Colorectal Surgery

Effects of Dexmedetomidine-Assisted Total Intravenous Anesthesia on Intraoperative Hemodynamic Fluctuations During the Maintenance Phase and Postoperative Recovery Quality in Patients Undergoing Laparoscopic Colorectal Surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600128572
Enrollment
Unknown
Registered
2026-07-22
Start date
2026-07-23
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal tumour

Interventions

Low-volatility group:None
Medium-wave group:None
High-volatility group:None

Sponsors

Meizhou People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Adult patients who are able to understand the study content and cooperate in completing the postoperative quality of recovery assessment; 2.Undergoing elective laparoscopic colorectal surgery; 3.Preoperative American Society of Anesthesiologists (ASA) physical status classification I–III, with relatively stable overall vital signs; 4.Scheduled to undergo surgery under total intravenous anesthesia, with dexmedetomidine used as an adjuvant medication during the anesthesia maintenance phase; 5.Complete routine intraoperative monitoring conditions are in place, allowing continuous and complete acquisition of hemodynamic data such as blood pressure and heart rate; 6.Able to complete the QoR-15 scale assessment within the specified time period after surgery; 7.Agree to the content of this clinical study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1.Preoperative presence of severe cardiovascular diseases, such as uncontrolled hypertension, severe arrhythmias, or significant cardiac insufficiency, which may significantly interfere with hemodynamic stability; 2.Concomitant severe hepatic or renal dysfunction, or endocrine system diseases that affect drug metabolism or stress response; 3.Intraoperative conversion to open surgery or occurrence of severe complications, causing the anesthesia and surgical process to deviate significantly from the routine pathway; 4.Occurrence of critical events requiring special intervention during surgery, such as severe hypotension or malignant arrhythmias; 5.Perioperative use of sedatives, analgesics, or vasoactive agents outside the study protocol, affecting the comparability of hemodynamic assessments; 6.Inability to complete the QoR-15 scale assessment postoperatively for various reasons, or missing data. By strictly excluding the above conditions, the influence of potential confounding factors on the study results will be reduced.

Design outcomes

Primary

MeasureTime frame
Quality of Recovery-15 total score at 24 hours postoperatively;

Secondary

MeasureTime frame
Duration of surgery;Incidence of Postoperative Nausea and Vomiting (PONV);Postoperative analgesic requirements;

Countries

China

Contacts

Public ContactShi Liang

Meizhou People's Hospital

shiliang@mzrmyy.com+86 753 21311614

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 10, 2026